Diosmetin inhibits osteoclast formation and differentiation and prevents LPS‐induced osteolysis in mice

S Shao, F Fu, Z Wang, F Song, C Li… - Journal of Cellular …, 2019 - Wiley Online Library
Osteolytic bone diseases are closely linked to the over‐activation of osteoclasts and
enhancement of bone resorption. It has become a major health issue in orthopedic practice …
被引用次数：21 相关文章

Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice

S Shao, F Fu, Z Wang, F Song… - Journal of …, 2019 - research-repository.uwa.edu.au
Osteolytic bone diseases are closely linked to the over-activation of osteoclasts and
enhancement of bone resorption. It has become a major health issue in orthopedic practice …

Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice

S Shao, F Fu, Z Wang, F Song, C Li… - Journal of cellular …, 2019 - pubmed.ncbi.nlm.nih.gov
Osteolytic bone diseases are closely linked to the over-activation of osteoclasts and
enhancement of bone resorption. It has become a major health issue in orthopedic practice …
[PDF] academia.edu

[PDF][PDF] Diosmetin inhibits osteoclast formation and differentiation

J Xu, Q Liu - academia.edu
Osteolytic bone diseases are closely linked to the over-activation of osteoclasts and
enhancement of bone resorption. It has become a major health issue in orthopedic practice …

Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.

S Shao, F Fu, Z Wang, F Song, C Li, ZX Wu… - Journal of Cellular …, 2018 - europepmc.org
Osteolytic bone diseases are closely linked to the over-activation of osteoclasts and
enhancement of bone resorption. It has become a major health issue in orthopedic practice …